A Promising Breakthrough for Triple‐Negative Breast Cancer by Targeting the AKT and EZH2

A Promising Breakthrough for Triple‐Negative Breast Cancer by Targeting the AKT and EZH2

Saved in:

Bibliographic Details
Main Authors:	Zhuoyun Liu, Yirong Li, Xinghua Long
Format:	Article
Language:	English
Published:	Wiley 2025-08-01
Series:	MedComm
Online Access:	https://doi.org/10.1002/mco2.70318
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

USP44 promotes chemotherapeutic drug resistance of triple negative breast cancer through EZH2 protein stability
by: Pu Wu, et al.
Published: (2025-12-01)

Dual inhibition of AKT and autophagy sensitizes triple negative breast cancer cells to carboplatin
by: Jun-zhen Zhou, et al.
Published: (2025-08-01)

AKT1 Phosphorylates FDX1 to Promote Cuproptosis Resistance in Triple‐Negative Breast Cancer
by: Zicheng Sun, et al.
Published: (2025-05-01)

Triple-Negative Breast Cancer
by: Quyen D. Chu, et al.
Published: (2012-01-01)

Targeting RTKs/nRTKs as promising therapeutic strategies for the treatment of triple-negative breast cancer: evidence from clinical trials
by: Kasshish Mehta, et al.
Published: (2024-12-01)

Co-Inhibition of PARP and STAT3 as a Promising Approach for Triple-Negative Breast Cancer
by: Changyou Shi, et al.
Published: (2025-07-01)

Targeting EZH2 in Cancer: Mechanisms, Pathways, and Therapeutic Potential
by: Maria Saveria Gilardini Montani, et al.
Published: (2024-12-01)

Targeting a cell state common to triple‐negative breast cancers
by: Markus K Muellner, et al.
Published: (2015-02-01)

Translational drugs targeting cancer stem cells in triple-negative breast cancer
by: Felipe P. de Oliveira, et al.
Published: (2025-09-01)

E2F-1–Akt1 Interaction as Precursor to Cisplatin-induced Apoptosis in Triple-negative Breast Cancer Cells
by: Samiya Al-Jaaidi, et al.
Published: (2025-01-01)

Capsanthin inhibits migration and reduces N-linked glycosylation of PD-L1 via the EZH2-PD-L1 axis in triple-negative breast cancer brain metastasis
by: Yi-Chung Chien, et al.
Published: (2025-03-01)

TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER
by: A. D. Zikiryakhodzhaev, et al.
Published: (2017-06-01)

Characterization of Triple Negative Breast Cancer
by: Bernardo Enrique Heredia Martínez, et al.
Published: (2020-09-01)

Molecular profiling of breast cancer methylation pattern in triple negative versus non- triple negative breast cancer
by: Marwa Mohanad, et al.
Published: (2025-02-01)

Targeting PRDX2 to inhibit tumor growth and metastasis in triple-negative breast cancer: the role of FN1 and the PI3K/AKT/SP1 pathway
by: Jiawei Zhou, et al.
Published: (2025-04-01)

Prognostic Potential of AKR1B1 in triple-negative breast cancer
by: Xiong Jing, et al.
Published: (2025-01-01)

IQGAP1 is a Specific Target of Haldol in Triple Negative Breast Cancer
by: Mahmood Meqdad
Published: (2025-06-01)

Targeted Treatment of Metastatic Triple-Negative Breast Cancer: A Systematic Review
by: Anna Martha Hammershøi Madsen, et al.
Published: (2024-01-01)

Therapies targeting triple-negative breast cancer: a perspective on anti-FGFR
by: Jinhao Chen, et al.
Published: (2025-03-01)

Targeting TUBB2B inhibits triple-negative breast cancer growth and brain-metastatic colonization
by: Qingling He, et al.
Published: (2025-02-01)

Brain Metastasis in Triple-Negative Breast Cancer
by: Eduarda Bustamante, et al.
Published: (2024-01-01)

Collagen architecture in triple negative breast cancer.
by: Zoë Dinkel, et al.
Published: (2025-01-01)

Mechanisms of radioresistance and radiosensitization strategies for Triple Negative Breast Cancer
by: Yuxuan Wang, et al.
Published: (2025-05-01)

EPHA2 promotes triple-negative breast cancer progression by suppressing pyroptosis via the AKT/PI3K/mTOR pathway
by: Xiaoying Huang, et al.
Published: (2025-08-01)

Dual targeting of CXCR4 and EZH2 in endometriosis
by: Sarah Brunty, et al.
Published: (2025-04-01)

Ketone drink enhances therapeutic efficacy in prostate cancer by targeting EZH2
by: Chaehyun Yum, et al.
Published: (2025-07-01)

Molecular subtyping and target identification in triple negative breast cancer through immunohistochemistry biomarkers
by: Rima Saad Bouzid, et al.
Published: (2025-03-01)

Hyaluronic acid-functionalized supramolecular nanophotosensitizers for targeted photoimmunotherapy of triple-negative breast cancer
by: Haiyan Zhang, et al.
Published: (2024-12-01)

SP1 promotes triple-negative breast cancer progression by targeting USP5
by: Shi-Yi Wu, et al.
Published: (2025-05-01)

Saikosaponin A induces cellular senescence in triple-negative breast cancer by inhibiting the PI3K/Akt signalling pathway
by: Yingchao Wu, et al.
Published: (2025-04-01)

Characterizing SSTR2 expression and modulation for targeted imaging and therapy in preclinical models of triple-negative breast cancer
by: Shannon E. Lynch, et al.
Published: (2025-03-01)

Delineation of the Germline and Somatic Mutation Interaction Landscape in Triple-Negative and Non-Triple-Negative Breast Cancer
by: Jiande Wu, et al.
Published: (2020-01-01)

Results of combination treatment for triple-negative breast cancer
by: M. A. Sekundova, et al.
Published: (2014-07-01)

Role of Glucocorticoid Receptor in Triple-Negative Breast Cancer
by: Raj Kumar
Published: (2025-04-01)

What is the future in the treatment of triple-negative breast cancer?
by: Erdinc Nayir, MD
Published: (2017-12-01)

Tumor-infiltrating lymphocytes in triple negative breast cancer
by: L. M. Zakhartseva, et al.
Published: (2020-12-01)

Triple negative breast cancer: A continuing challenge
by: Sudeep Gupta
Published: (2013-01-01)

CircASH1L-mediated tumor progression in triple-negative breast cancer: PI3K/AKT pathway mechanisms
by: Liu Haiyan, et al.
Published: (2025-08-01)

Development of Multifunctional Targeted Dual-Loaded Polymeric Nanoparticles for Triple-Negative Breast Cancer Treatment
by: Gantumur Battogtokh, et al.
Published: (2025-03-01)

Amine-Terminated Silver Nanoparticles Exhibit Potential for Selective Targeting of Triple-Negative Breast Cancer
by: Jayshree H. Ahire, et al.
Published: (2024-10-01)